Bora生物logics公司扩大了其圣地亚哥设施,更新了3 000万美元,以促进生物药物生产和创造就业机会。 Bora Biologics expanded its San Diego facility with a $30 million upgrade to boost biologic drug production and create jobs.

Bora Biologics在其圣迭戈林业发展局注册的设施中开设了3 000万美元的扩建项目,增加了先进的生物反应器和净化系统,以促进大规模生物制造。 Bora Biologics opened a $30 million expansion at its San Diego FDA-registered facility, adding advanced bioreactors and purification systems to boost large-scale biologic manufacturing. 升级提高了细胞文化疗法的能力,并支持客户从发展到商业供应。 The upgrade enhances capacity for cell culture therapies and supports clients from development to commercial supply. 公司和城市领导人强调创造就业机会和区域经济增长,强调该项目在加强美国生物制造业和地方生命科学部门方面的作用。 Company and city leaders highlighted job creation and regional economic growth, underscoring the project’s role in strengthening U.S. biomanufacturing and the local life sciences sector.